LAS VEGAS, June 22 /PRNewswire-FirstCall/ -- (BULLETIN BOARD: PYTL) The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
PhytoLabs new, now patented extract, developed by leading research scientists at the National Center for Natural Products Research (NCNPR) at the University of Mississippi "... is one of the most promising projects our Center has produced in recent years, including its intellectual property," says Dr. Walter G. Chambliss, Director of Technology Management at the University of Mississippi. "Our research has shown that this extract is the most powerful, natural immune-stimulatory dietary supplement discovered to date ..." said co-inventor Dr. David Pasco, Assistant Director at NCNPR. The results of this research were published in Planta Medica (Pugh et al, 2001 67(8): 737-742). The patent is the result of nearly ten years of research. "This is tremendous validation for this powerful immune extract," said COO, David Wood.
The all-natural, low-dosage extract is standardized to immune bioactivity. "The interesting aspect of the extract is that it seems to put the immune system's first line of defence on a higher level of alert, making it better prepared to cope with any challenges the body is faced with. At the same time, clinical research has shown a very high degree of safety," commented co-inventor Dr. Nirmal Pugh, Research Scientist at NCNPR. Additional clinical trials aimed at further substantiating health effects are currently underway in the United States and Europe.
The NCNPR is the only university-affiliated research center in the United States devoted to improving human health and agricultural productivity through the discovery, development, and commercialization of pharmaceuticals and agrochemicals derived from natural products. The Center has a cooperative agreement with the Food and Drug Administration (FDA) to help assess the safety of botanical dietary supplements.
About PhytoLabs Inc.
Phytolabs Inc. ("PYTL") is a life science company focused on the global commercialization of unique, patented and scientifically proven self-medication health products. They offer products that allow a proactive health management approach by delivering the highest levels of effectiveness, safety, and prevention. Further information on PhytoLabs Inc. is available at http://www.phytolabsinc.com/.
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products or actions in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.
© 2007 PR Newswire
